promacta

Nov 11, 2026

Summary More than $300 billion of annual revenue, about one-sixth of the industry, loses exclusivity between 2025 and 2030, roughly three times the 2012 cliff. Branded sales can fall 80–90% within 12 to 18 months of generic or biosimilar entry, and US Medicare price negotiation can cut net prices even earlie...

May 25, 2020

The Immune Thrombocytopenia market size in the 7MM was estimated to be approximately USD 2,527.72 million in 2017. The US accounts for the largest ITP Market size. A disorder that results in an isolated low platelet count, Immune thrombocytopenia (ITP), is an autoimmune disorder that results in convincing body...